CoChat

Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer

Open access
Carnielli, Carolina Moretto, Macedo, Carolina Carneiro Soares, De Rossi, Tatiane, Granato, Daniela Campos, Rivera, César, Domingues, Romênia Ramos, Pauletti, Bianca Alves, Yokoo, Sami, Heberle, Henry, Busso-Lopes, Ariane Fidelis, Cervigne, Nilva Karla, Sawazaki-Calone, Iris, Meirelles, Gabriela Vaz, Marchi, Fábio Albuquerque, Telles, Guilherme Pimentel, Minghim, Rosane, Ribeiro, Ana Carolina Prado, Brandão, Thaís Bianca, de Castro, Gilberto, González-Arriagada, Wilfredo Alejandro, Gomes, Alexandre, Penteado, Fabio, Santos-Silva, Alan Roger, Lopes, Márcio Ajudarte, Rodrigues, Priscila Campioni, Sundquist, Elias, Salo, Tuula, da Silva, Sabrina Daniela, Alaoui-Jamali, Moulay A., Graner, Edgard, Fox, Jay W., Coletta, Ricardo Della, Paes Leme, Adriana Franco · 2018 · Nature Communications
Cited by 194

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Different regions of oral squamous cell carcinoma (OSCC) have particular histopathological and molecular characteristics limiting the standard tumor−node−metastasis prognosis classification. Therefore, defining biological signatures that allow assessing the prognostic outcomes for OSCC patients would be of great clinical significance. Using histopathology-guided discovery proteomics, we analyze neoplastic islands and stroma from the invasive tumor front (ITF) and inner tumor to identify differentially expressed proteins. Potential signature proteins are prioritized and further investigated by immunohistochemistry (IHC) and targeted proteomics. IHC indicates low expression of cystatin-B in neoplastic islands from the ITF as an independent marker for local recurrence. Targeted proteomics analysis of the prioritized proteins in saliva, combined with machine-learning methods, highlights a peptide-based signature as the most powerful predictor to distinguish patients with and without lymph node metastasis. In summary, we identify a robust signature, which may enhance prognostic decisions in OSCC and better guide treatment to reduce tumor recurrence or lymph node metastasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-05696-2

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 194

Metadata

Authors
Carnielli, C. M., Macedo, C. C. S., De Rossi, T., Granato, D. C., Rivera, C., Domingues, R. R., Pauletti, B. A., Yokoo, S., Heberle, H., Busso-Lopes, A. F., Cervigne, N. K., Sawazaki-Calone, I., Meirelles, G. V., Marchi, F. A., Telles, G. P., Minghim, R., Ribeiro, A. C. P., Brandão, T. B., de Castro, G., González-Arriagada, W. A., Gomes, A., Penteado, F., Santos-Silva, A. R., Lopes, M. A., Rodrigues, P. C., Sundquist, E., Salo, T., da Silva, S. D., Alaoui-Jamali, M. A., Graner, E., Fox, J. W., Coletta, R. D., & Paes Leme, A. F.
Venue
Nature Communications
Published
2018-09-05
Volume
9
Issue
1
Pages
3598-3598
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2889150713
Cited by
194
References
11
FWCI
16.15
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer. https://app.cochat.ai/papers/10.1038/s41467-018-05696-2
The paper
Carnielli, C. M., Macedo, C. C. S., De Rossi, T., Granato, D. C., Rivera, C., Domingues, R. R., Pauletti, B. A., Yokoo, S., Heberle, H., Busso-Lopes, A. F., Cervigne, N. K., Sawazaki-Calone, I., Meirelles, G. V., Marchi, F. A., Telles, G. P., Minghim, R., Ribeiro, A. C. P., Brandão, T. B., de Castro, G., . . . Paes Leme, A. F. (2018). Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer. Nature Communications. https://doi.org/10.1038/s41467-018-05696-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.